The global sepsis diagnostics market size was US$ 570 million in 2021. The global sepsis diagnostics market size is forecast to reach US$ 1,111.26 million by 2030, growing at a compound annual growth rate (CAGR) of 7.7% during the forecast period from 2022 to 2030.

Sepsis develops when the host's immune system reacts to an infection and releases chemicals to combat the infection. It inflames the entire body as it enters the bloodstream. It causes blood clots, blood vessel leakage, and poor blood flow and deprives the body's essential organs of oxygen and nutrition. The current sepsis diagnostic techniques focus on general physiological and clinical parameters. The blood test is the first line of defense against infection, blood clotting, and decreased oxygen availability. Following this are further laboratory tests such as urine, wound secretions, and respiratory secretions. If the source of inflammation and the confirmation of sepsis cannot be determined using these procedures, then X-rays, computed tomography, ultrasound, and resonance imaging (MRI) are used.

Factors Influencing Market Growth
The increased prevalence of sepsis, rising awareness, and the advent of technologically advanced diagnostic solutions drive the global market.

The increasing number of surgical procedures and rising number of product approvals for the diagnosis of sepsis boost the global market growth.

The limited availability of skilled professionals may slow down the overall market growth.

Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global market. Global COVID-19 outbreaks and the emergence of sepsis among COVID-19 patients are likely to lead to more demand for rapid diagnosis, resulting in more devices, reagents, and test kits being adopted. The dangers that older people confront have come to light due to the global crisis. In addition, older people were more susceptible to complications like acute respiratory distress syndrome (ARDS), caused by pneumonia and resulting in sepsis. Thus, the need for early sepsis diagnosis in patients with COVID-19 infections increased.

Regional Analysis
The Asia Pacific region garnered a substantial market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the growing demand for sepsis diagnostic solutions in countries with an increased prevalence of infectious diseases, such as Algeria and Morocco.

North America is forecast to have considerable growth during the forecast period. As a result of the existence of a highly developed healthcare system, increased adoption of innovative sepsis diagnostics technology, and technological improvement in the field of sepsis diagnostics.

Leading Competitors
The leading prominent companies profiled in the global sepsis diagnostics market are:
BioMerieux SA
Thermo Fisher Scientific Inc.
Abbott Laboratories, Inc.
Becton, Dickinson, and Company
Bruker Corporation
Beckman Coulter, Inc.
T2 Biosystems, Inc
Nanosphere, Inc.
Hoffmann-LA Roche Ltd
Danaher Corporation
Other Prominent Players

Scope of the Report
The global sepsis diagnostics market segmentation focuses on Method, Product, Technology, Usability, Pathogen, End-User, and Region.
Segmentation based on Method
Conventional Diagnostics
Automated Diagnostics
Segmentation based on Product
Blood Culture Media
Instruments
Assay kits & Reagents
Software
Segmentation based on Technology
Microbiology
Molecular Diagnostics
o PCR
o Peptide Nucleic Acid-Fluorescent In Situ Hybridization
o Microarrays
o DNA sequencing
o Syndromic Panel-Based Testing
Immunoassays
Flow Cytometry
Microfluidics
Flow Cytometry
Segmentation based on Usability
Laboratory Testing
Point-of-care Testing
Segmentation based on Pathogen
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Viral Sepsis
Others
Segmentation based on End-User
Hospitals and specialty clinics
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Sepsis Diagnostics Market Size, Share, Insight, and Forecast 2022 to 2030
Meta Description: Global Sepsis Diagnostics Market is projected to reach US$ 1,111.26 million by the end of 2030 from US$ 570 million in 2021, at a CAGR of 7.7%
Meta Keywords: sepsis diagnostics market Size, sepsis diagnostics market share, sepsis diagnostics market trend, sepsis diagnostics market Forecast, sepsis diagnostics market